Test to detect risky changes in pancreatic cysts
Part of Cancer, Digestive system clinical trials.
This study looks for molecular (lab) signals that may show advanced or higher-risk changes in certain pancreatic cysts. It may help doctors better sort which cysts are more concerning and may need closer attention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic cyst that meets criteria doctors consider “worrisome” or “high-risk.”
- Your doctors suspect the cyst could be a pancreatic cystic tumor (a growth that comes from the cyst lining).
- You must be able and willing to sign written consent.
- You are not pregnant or breastfeeding.
- Your scans do not already suggest pancreatic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
This study looks at patients who have been referred for evaluation of a pancreatic cyst. It aims to improve how doctors estimate risk and predict how cysts may change over time.
This study looks for “biomarkers,” or measurable lab signals, in blood and (when available) cyst fluid to understand pancreatic cyst problems and related conditions. It may help doctors better predict what these conditions are and how to manage them.
Hear when a new Pancreas Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.